Kalaris Therapeutics Inc (KLRS) NASDAQ
8.67
-0.5(-5.45%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
8.67
-0.5(-5.45%)
Currency In USD
Address
139 Main Street, Suite 500
Cambridge, MA 02142
United States of America (the)
Phone
N/A
Website
Sector
Healthcare
Industry
Biotechnology
Employees
14
First IPO Date
July 30, 2020
| Name | Title | Pay | Year Born |
| Andrew Oxtoby | President, Chief Executive Officer & Director | 660,130 | 1974 |
| Matthew Feinsod | Chief Medical Officer | 0 | 1971 |
| Michael Philip Dybbs | Director & Co-Founder | 0 | 1975 |
| Srinivas Akkaraju | Director & Co-Founder | 0 | 1968 |
| Napoleone Ferrara | Independent Director & Co-Founder | 0 | 1957 |
| Brett R. Hagen | Chief Accounting Officer | 0 | 1973 |
| Matthew Gall | Chief Financial Officer & Treasurer | 0 | 1976 |
| Kristine Curtiss | Senior Vice President of Clinical | 0 | N/A |
Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.